Skip to main content
. 1999 May 29;318(7196):1443–1450. doi: 10.1136/bmj.318.7196.1443

Table 5.

Summary of studies that have examined cancer risk of cancer in children whose fathers were monitored for occupational exposure to ionising radiation before their conception.* Values are risk ratios (95% confidence intervals) unless stated otherwise

West Cumbria12 Caithness14 West Berkshire16 Ontario45 Record linkage study22
Present study
All data Without west Cumbria All data Without Cumbria
Study description
Design Case-control Case-control Case-control Case-control Case-control Cohort
Age range(years) 0–24 0–24 0–4 0–14 0–14 0–24
Years of diagnosis 1950–85 1970–86 1972–89 1950–88 1952–1986 1 1951–1993
All malignancies
Monitored No data No data No data No data 1.3 (0.9 to 1.9) 1.3 (0.9 to 1.9) 1.4 (0.9 to 2.2) 1.5 (0.9 to 2.5)
⩾ 100 mSv No data No data No data No data 1.2 (0.3 to 4.3) 0.7 (0.1 to 3.4) 2.2 (0.9 to 5.3)  4.1 (1.4 to 11.8)
Leukaemia and non-Hodgkin’s lymphoma
Monitored 1.1 (0.5 to 2.7) Not reported 9.0 (1.0 to 108.8) No data 1.8 (1.1 to 3.0) 1.8 (1.1 to 3.0) 1.8 (0.7 to 4.4) 2.2 (0.7 to 6.6)
⩾100 mSv  8.6 (1.4 to 52.2) 0.0 No data No data 1.4 (0.3 to 7.2) 0.5 (0.0 to 5.2)  3.9 (1.0 to 15.7)  4.3 (0.5 to 40.5)
Leukaemia
Monitored 1.4 (0.5 to 3.9) Not reported Not reported 1.0 (0.5 to 2.2) Not reported Not reported 2.2 (0.8 to 6.1)  2.9 (0.8 to 10.3)
⩾ 100 mSv  8.4 (1.4 to 52.0) Not reported No data 0.0 Not reported Not reported  5.8 (1.3 to 24.8)  6.6 (0.7 to 67.1)
All malignancies except leukaemia and non-Hodgkin’s lymphoma
Monitored No data No data No data No data 0.9 (0.6 to 1.6) 1.3 (0.7 to 2.2) 1.3 (0.7 to 2.3)
⩾ 100 mSv No data No data No data No data  1.0 (0.1 to 13.8) 1.5 (0.5 to 5.0)  4.0 (1.2 to 13.6)
*

Further details of these studies are shown in table 6. Results from Kinlen et al’s study20 are not shown since their data were included in the record-linkage study.22 23 Findings from the case-control study conducted near the La Hague plant are also not shown since no estimates of risk were reported for monitored workers and there were no reports of workers with doses of 100 mSv or more.46